All posts
AI Infrastructure
Hana Health

Why 89% of Healthcare AI Never Reaches Production (And What the 11% Do Differently)

I remember watching a Stripe dashboard hit a million dollars in a single day. DTC business, years ago. The product was mediocre. The scale was undeniable. And I remember thinking: scale doesn’t validate anything. It amplifies whatever’s already there.

Good products get better. Bad products break in more expensive ways.

Healthcare AI is living that lesson right now. Billions invested. Genuine capability. And only 11% of AI agents actually reach production. The rest fail, quietly, in pilot hell or in the wreckage of a workflow that went wrong in ways no one anticipated. The gap isn’t intelligence. It’s architecture.

Why Do Most Healthcare AI Projects Fail Before Reaching Production?

Most healthcare AI projects fail before reaching production because organizations invest in AI capability without building the governance layer that makes autonomous action safe in clinical environments.

Corti, a specialized healthcare AI lab, put a number on this in February 2026: only 11% of healthcare AI agents reach production. The rest don’t fail because the AI is wrong. They fail because when the AI makes a mistake in an interconnected clinical workflow, the error cascades faster than any human can catch it.

They called it a “safety spiral.”

That phrase stuck with me. Because it perfectly describes something I’ve seen in clinical settings, and in every other high-stakes system I’ve worked in. An error doesn’t stay where it started. It moves.

What Is a Safety Spiral in Clinical AI?

A safety spiral is what happens when an unsupervised AI agent makes an error in one part of a clinical workflow and that error propagates through connected systems before anyone notices. The downstream systems accept the error as valid input. By the time a human sees something wrong, the damage has already moved several steps forward.

This is the actual reason AI hasn’t replaced clinical labor at scale, despite years of investment and genuine capability.

It’s not a data problem. It’s not a model quality problem. It’s a governance problem. Clinical environments are interconnected in ways that make cascading errors genuinely dangerous. Prior authorization touches prescriptions touches patient safety. Medical coding touches billing touches downstream care decisions. Documentation shapes every clinical judgment that follows. Autonomous AI without governed orchestration in those environments isn’t helpful. It’s a liability.

What Does Healthcare AI Infrastructure Actually Need to Work?

Healthcare AI infrastructure needs three things to operate safely at production scale: deterministic validation of every agent action before execution, complete audit trails for regulatory compliance, and governance built into the orchestration layer rather than added afterwards.

This is what separates the 11% who get to production from the 89% who don’t.

The organizations that actually deploy AI in clinical workflows treat governance as a first-class engineering problem. They don’t start from “what can this AI do?” They start from “what is this AI allowed to do, and how do we verify that in real time?” That’s a different design philosophy. It produces different infrastructure. And it produces different outcomes for patients.

Why Does Self-Hosted, Open-Source AI Matter for Clinical Deployment?

Self-hosted, open-source AI matters for clinical deployment because data sovereignty isn’t a contractual question. It’s an architectural one. When PHI runs through a third-party API, a BAA doesn’t eliminate the risk. It documents your agreement about who’s responsible after something goes wrong.

HANA is fully open-source and self-hosted, with no OpenAI dependency. That’s not a technical preference. It’s a clinical trust position.

Healthcare organizations that have watched vendor after vendor promise HIPAA compliance while routing sensitive patient data through opaque infrastructure understand why this matters. You can’t contractually eliminate a technical risk. You eliminate it by changing the architecture so the risk doesn’t exist structurally. When PHI never leaves your perimeter, the exposure question has a clean answer. We’ve run over a million patient interactions across five countries with zero critical adverse events. That record comes from governance built into the design, not appended to it.

What Does Governed AI Autonomy Look Like in Real Clinical Settings?

Governed AI autonomy in clinical settings means the AI operates within explicitly defined, validated boundaries. Every action is checked against clinical protocols before execution. Complex cases escalate to humans with full context intact. The audit trail is complete. Nothing happens that can’t be explained, reviewed, and defended.

It’s the difference between an agent that does what seems right and an agent that does what it’s been validated to do.

That distinction matters enormously when you’re running post-discharge follow-up calls, monitoring medication adherence, or managing any interaction where a missed escalation has real clinical consequences. At HANA, every voice interaction has structured escalation logic built in. The AI doesn’t decide unilaterally that something is fine. It follows validated clinical criteria and surfaces concerns to the right person at the right time. Across five countries and three languages, that governance structure has held.

What Should Clinics Ask When Evaluating Healthcare AI Vendors?

Clinics evaluating healthcare AI vendors should ask three questions before anything else: where does patient data go, who validates what the AI is allowed to do, and what happens when the AI is wrong.

If a vendor can’t answer all three cleanly, that’s the answer.

The gap in healthcare AI isn’t intelligence. The models are genuinely capable. The gap is whether the organization deploying them has built the systems to govern them safely in production. Most haven’t. That’s why 89% never make it. And why the organizations that do make it treat safety infrastructure as their primary engineering problem, not a compliance checkbox they hand off to legal.

If you’re evaluating voice AI for your patient follow-up program and want to see how governed clinical autonomy actually works, let’s walk through it together.